Syntex (U.S.A.) LLC
Records under this name other than patents Syntex (U.S.A.) LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,476,676 | Methods for Increasing Bone Formation Using Inhibitors of Glycogen Synthase KINASE-3 Betta Term ended Term ended Aug 11, 2025 · High confidence | Term ended | Term ended Aug 11, 2025 | High confidence |
| US 6,849,657 | 2-Pyrrolidone Derivatives as Prostanoid Agonists Formerly held Term ended Term ended Jul 16, 2022 · High confidence | Term ended | Term ended Jul 16, 2022 | High confidence |
| US 6,784,166 | 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Formerly held Term ended Term ended Jun 11, 2022 · High confidence | Term ended | Term ended Jun 11, 2022 | High confidence |
| US 6,696,566 | 6-Substituted Pyrido-Pyrimidines Term ended Term ended Mar 4, 2022 · High confidence | Term ended | Term ended Mar 4, 2022 | High confidence |
| US 8,648,054 | 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Formerly held Lapsed on the fee record Ended Feb 11, 2022 · Low confidence | Lapsed on the fee record | Ended Feb 11, 2022 | Low confidence |
| US 7,608,601 | 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication Formerly held Lapsed on the fee record Ended Oct 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2021 | From the USPTO record |
| US 6,777,418 | Retinoid Compounds (I) Term ended Term ended Oct 1, 2021 · High confidence | Term ended | Term ended Oct 1, 2021 | High confidence |
| US 6,667,301 | Heterocyclylalkylamines as Muscarinic Receptor Antagonists Term ended Term ended May 27, 2021 · High confidence | Term ended | Term ended May 27, 2021 | High confidence |
| US 7,491,711 | Methods of Treatment Using 3-Desoxy Vitamin D3 Analogs Lapsed on the fee record Ended Feb 17, 2021 · Medium confidence | Lapsed on the fee record | Ended Feb 17, 2021 | Medium confidence |
| US 6,515,198 | Use of Purinergic Receptor Modulators and Related Reagents Term ended Term ended Feb 13, 2021 · High confidence | Term ended | Term ended Feb 13, 2021 | High confidence |